BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu JB, Yin L, Shi C, Li Q, Duan P, Huang JM, Liu C, Wang F, Lewis M, Wang Y, Lin TP, Pan CC, Posadas EM, Zhau HE, Chung LWK. MAOA-Dependent Activation of Shh-IL6-RANKL Signaling Network Promotes Prostate Cancer Metastasis by Engaging Tumor-Stromal Cell Interactions. Cancer Cell. 2017;31:368-382. [PMID: 28292438 DOI: 10.1016/j.ccell.2017.02.003] [Cited by in Crossref: 60] [Cited by in F6Publishing: 68] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Al-Nakouzi N, Wang CK, Oo HZ, Nelepcu I, Lallous N, Spliid CB, Khazamipour N, Lo J, Truong S, Collins C, Hui D, Esfandnia S, Adomat H, Clausen TM, Gustavsson T, Choudhary S, Dagil R, Corey E, Wang Y, Chauchereau A, Fazli L, Esko JD, Salanti A, Nelson PS, Gleave ME, Daugaard M. Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer. Nat Commun 2022;13:4760. [PMID: 35963852 DOI: 10.1038/s41467-022-32530-7] [Reference Citation Analysis]
2 Li Y, Cao S, Gaculenko A, Zhan Y, Bozec A, Chen X. Distinct Metabolism of Bone Marrow Adipocytes and their Role in Bone Metastasis. Front Endocrinol 2022;13:902033. [DOI: 10.3389/fendo.2022.902033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shui X, Ren X, Xu R, Xie Q, Hu Y, Qin J, Meng H, Zhang C, Zhao J, Shi C. Monoamine oxidase A drives neuroendocrine differentiation in prostate cancer. Biochemical and Biophysical Research Communications 2022;606:135-41. [DOI: 10.1016/j.bbrc.2022.03.096] [Reference Citation Analysis]
4 Zhang X, Liu Q, Zhang T, Gao P, Wang H, Yao L, Huang J, Jiang S. Bone-targeted nanoplatform enables efficient modulation of bone tumor microenvironment for prostate cancer bone metastasis treatment. Drug Deliv 2022;29:889-905. [PMID: 35285760 DOI: 10.1080/10717544.2022.2050845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wang J, Du X, Wang X, Xiao H, Jing N, Xue W, Dong B, Gao WQ, Fang YX. Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis. Cancer Lett 2022;526:76-90. [PMID: 34801597 DOI: 10.1016/j.canlet.2021.11.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ojha R, Chen IC, Hsieh CM, Nepali K, Lai RW, Hsu KC, Lin TE, Pan SL, Chen MC, Liou JP. Installation of Pargyline, a LSD1 Inhibitor, in the HDAC Inhibitory Template Culminated in the Identification of a Tractable Antiprostate Cancer Agent. J Med Chem 2021;64:17824-45. [PMID: 34908406 DOI: 10.1021/acs.jmedchem.1c00966] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Putnins EE, Goebeler V, Ostadkarampour M. Monoamine Oxidase-B Inhibitor Reduction in Pro-Inflammatory Cytokines Mediated by Inhibition of cAMP-PKA/EPAC Signaling. Front Pharmacol 2021;12:741460. [PMID: 34867348 DOI: 10.3389/fphar.2021.741460] [Reference Citation Analysis]
8 Batoon L, McCauley LK. Cross Talk Between Macrophages and Cancer Cells in the Bone Metastatic Environment. Front Endocrinol (Lausanne) 2021;12:763846. [PMID: 34803925 DOI: 10.3389/fendo.2021.763846] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Tian J, Zhang C, Kang N, Wang J, Kong N, Zhou J, Wu M, Ding L, Sun H, Yan G, Sheng X. Attenuated monoamine oxidase a impairs endometrial receptivity in women with adenomyosis via downregulation of FOXO1. Biol Reprod 2021:ioab182. [PMID: 34568943 DOI: 10.1093/biolre/ioab182] [Reference Citation Analysis]
10 Herranz C, Mateo F, Baiges A, Ruiz de Garibay G, Junza A, Johnson SR, Miller S, García N, Capellades J, Gómez A, Vidal A, Palomero L, Espín R, Extremera AI, Blommaert E, Revilla-López E, Saez B, Gómez-Ollés S, Ancochea J, Valenzuela C, Alonso T, Ussetti P, Laporta R, Xaubet A, Rodríguez-Portal JA, Montes-Worboys A, Machahua C, Bordas J, Menendez JA, Cruzado JM, Guiteras R, Bontoux C, La Motta C, Noguera-Castells A, Mancino M, Lastra E, Rigo-Bonnin R, Perales JC, Viñals F, Lahiguera A, Zhang X, Cuadras D, van Moorsel CHM, van der Vis JJ, Quanjel MJR, Filippakis H, Hakem R, Gorrini C, Ferrer M, Ugun-Klusek A, Billett E, Radzikowska E, Casanova Á, Molina-Molina M, Roman A, Yanes O, Pujana MA. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis. EMBO Mol Med 2021;:e13929. [PMID: 34378323 DOI: 10.15252/emmm.202113929] [Reference Citation Analysis]
11 Atkinson SP. A preview of selected articles. Stem Cells Transl Med 2020;9:725-7. [PMID: 32573117 DOI: 10.1002/sctm.20-0215] [Reference Citation Analysis]
12 Wei J, Yin L, Li J, Wang J, Pu T, Duan P, Lin TP, Gao AC, Wu BJ. Bidirectional Cross-talk between MAOA and AR Promotes Hormone-Dependent and Castration-Resistant Prostate Cancer. Cancer Res 2021;81:4275-89. [PMID: 34167949 DOI: 10.1158/0008-5472.CAN-21-0198] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Wang YC, Wang X, Yu J, Ma F, Li Z, Zhou Y, Zeng S, Ma X, Li YR, Neal A, Huang J, To A, Clarke N, Memarzadeh S, Pellegrini M, Yang L. Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy. Nat Commun 2021;12:3530. [PMID: 34112755 DOI: 10.1038/s41467-021-23164-2] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
14 Yoshida S, Shimo T, Takabatake K, Murase Y, Obata K, Okui T, Kunisada Y, Ibaragi S, Nagatsuka H, Sasaki A. Expression of Neurokinin B Receptor in the Gingival Squamous Cell Carcinoma Bone Microenvironment. Diagnostics (Basel) 2021;11:1044. [PMID: 34200131 DOI: 10.3390/diagnostics11061044] [Reference Citation Analysis]
15 Ostadkarampour M, Putnins EE. Monoamine Oxidase Inhibitors: A Review of Their Anti-Inflammatory Therapeutic Potential and Mechanisms of Action. Front Pharmacol 2021;12:676239. [PMID: 33995107 DOI: 10.3389/fphar.2021.676239] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
16 Hofbauer LC, Bozec A, Rauner M, Jakob F, Perner S, Pantel K. Novel approaches to target the microenvironment of bone metastasis. Nat Rev Clin Oncol 2021;18:488-505. [PMID: 33875860 DOI: 10.1038/s41571-021-00499-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
17 Puhr M, Eigentler A, Handle F, Hackl H, Ploner C, Heidegger I, Schaefer G, Brandt MP, Hoefer J, Van der Pluijm G, Klocker H. Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer. Oncogene 2021;40:3087-100. [PMID: 33795839 DOI: 10.1038/s41388-021-01754-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhang B, Li Y, Wu Q, Xie L, Barwick B, Fu C, Li X, Wu D, Xia S, Chen J, Qian WP, Yang L, Osunkoya AO, Boise L, Vertino PM, Zhao Y, Li M, Chen HR, Kowalski J, Kucuk O, Zhou W, Dong JT. Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer. Nat Commun 2021;12:1714. [PMID: 33731701 DOI: 10.1038/s41467-021-21976-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
19 Jia C, Cheng C, Li T, Chen X, Yang Y, Liu X, Li S, Le W. α-Synuclein Up-regulates Monoamine Oxidase A Expression and Activity via Trans-Acting Transcription Factor 1. Front Aging Neurosci 2021;13:653379. [PMID: 33815093 DOI: 10.3389/fnagi.2021.653379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ma RY, Zhang H, Li XF, Zhang CB, Selli C, Tagliavini G, Lam AD, Prost S, Sims AH, Hu HY, Ying T, Wang Z, Ye Z, Pollard JW, Qian BZ. Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth. J Exp Med 2020;217:e20191820. [PMID: 32780802 DOI: 10.1084/jem.20191820] [Cited by in Crossref: 13] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
21 Santin Y, Resta J, Parini A, Mialet-Perez J. Monoamine oxidases in age-associated diseases: New perspectives for old enzymes. Ageing Res Rev 2021;66:101256. [PMID: 33434685 DOI: 10.1016/j.arr.2021.101256] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 20.0] [Reference Citation Analysis]
22 Ma Q, Liang M, Wu Y, Dou C, Xu J, Dong S, Luo F. Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche. J Extracell Vesicles 2021;10:e12068. [PMID: 33659051 DOI: 10.1002/jev2.12068] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
23 Zhou J, Yang Z, Wu X, Zhang J, Zhai W, Chen Y. Identification of genes that correlate clear cell renal cell carcinoma and obesity and exhibit potential prognostic value. Transl Androl Urol 2021;10:680-91. [PMID: 33718070 DOI: 10.21037/tau-20-891] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Wang H, Pan J, Barsky L, Jacob JC, Zheng Y, Gao C, Wang S, Zhu W, Sun H, Lu L, Jia H, Zhao Y, Bruns C, Vago R, Dong Q, Qin L. Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways. Mol Biomed 2021;2:3. [PMID: 35006432 DOI: 10.1186/s43556-020-00022-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
25 Weber H, Ruoff R, Garabedian MJ. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen. PLoS Genet 2021;17:e1008540. [PMID: 33513133 DOI: 10.1371/journal.pgen.1008540] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Yin L, Li J, Wang J, Pu T, Wei J, Li Q, Wu BJ. MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1-cMET signaling. Oncogene 2021;40:1362-74. [PMID: 33420365 DOI: 10.1038/s41388-020-01615-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
27 Meenu M, Verma VK, Seth A, Sahoo RK, Gupta P, Arya DS. Association of Monoamine Oxidase A with Tumor Burden and Castration Resistance in Prostate Cancer. Curr Ther Res Clin Exp 2020;93:100610. [PMID: 33245296 DOI: 10.1016/j.curtheres.2020.100610] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Furesi G, Rauner M, Hofbauer LC. Emerging Players in Prostate Cancer-Bone Niche Communication. Trends Cancer 2021;7:112-21. [PMID: 33274720 DOI: 10.1016/j.trecan.2020.09.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
29 Lim EY, Park J, Kim YT, Kim MJ. Imipramine Inhibits Migration and Invasion in Metastatic Castration-Resistant Prostate Cancer PC-3 Cells via AKT-Mediated NF-κB Signaling Pathway. Molecules 2020;25:E4619. [PMID: 33050597 DOI: 10.3390/molecules25204619] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
30 Pang YY, Li JD, Gao L, Yang X, Dang YW, Lai ZF, Liu LM, Yang J, Wu HY, He RQ, Huang ZG, Xiong DD, Yang LH, Shi L, Mo WJ, Tang D, Lu HP, Chen G. The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues. Cancer Med 2020;9:8004-19. [PMID: 32931665 DOI: 10.1002/cam4.3434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
31 Yang X, Zhao D, Li Y, Li Y, Cui W, Li Y, Li H, Li X, Wang D. Potential monoamine oxidase A inhibitor suppressing paclitaxel-resistant non-small cell lung cancer metastasis and growth. Thorac Cancer 2020;11:2858-66. [PMID: 32875729 DOI: 10.1111/1759-7714.13617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Wang K, Luo J, Yeh S, You B, Meng J, Chang P, Niu Y, Li G, Lu C, Zhu Y, Antonarakis ES, Luo J, Huang CP, Xu W, Chang C. The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer. Nat Commun 2020;11:2689. [PMID: 32483206 DOI: 10.1038/s41467-020-15396-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
33 Zhang L, Yang Y, Liao Z, Liu Q, Lei X, Li M, Saijilafu, Zhang Z, Hong D, Zhu M, Li B, Yang H, Chen J. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade. Theranostics 2020;10:6638-60. [PMID: 32550895 DOI: 10.7150/thno.44793] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
34 Jia CC, Li G, Jiang R, Liu X, Yuan Q, Le W, Hou Y, Wang B. B-Cell Receptor-Associated Protein 31 Negatively Regulates the Expression of Monoamine Oxidase A Via R1. Front Mol Biosci 2020;7:64. [PMID: 32426368 DOI: 10.3389/fmolb.2020.00064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
35 Yang YC, Chien MH, Lai TC, Su CY, Jan YH, Hsiao M, Chen CL. Monoamine Oxidase B Expression Correlates with a Poor Prognosis in Colorectal Cancer Patients and Is Significantly Associated with Epithelial-to-Mesenchymal Transition-Related Gene Signatures. Int J Mol Sci 2020;21:E2813. [PMID: 32316576 DOI: 10.3390/ijms21082813] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
36 Zhang X, Zhang Y, Lin F, Shi X, Xiang L, Li L. Shh Overexpression Is Correlated with GRP78 and AR Expression in Primary Prostate Cancer: Clinicopathological Features and Outcomes in a Chinese Cohort. Cancer Manag Res 2020;12:1569-78. [PMID: 32184660 DOI: 10.2147/CMAR.S231218] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Li J, Pu T, Yin L, Li Q, Liao CP, Wu BJ. MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness. Oncogene 2020;39:3305-21. [PMID: 32066880 DOI: 10.1038/s41388-020-1217-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
38 Anselmino N, Starbuck M, Labanca E, Cotignola J, Navone N, Gueron G, Zenclussen AC, Vazquez E. Heme Oxygenase-1 Is a Pivotal Modulator of Bone Turnover and Remodeling: Molecular Implications for Prostate Cancer Bone Metastasis. Antioxid Redox Signal 2020;32:1243-58. [PMID: 31861963 DOI: 10.1089/ars.2019.7879] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
39 Zhou Q, Wang C, Zhu Y, Wu Q, Jiang Y, Huang Y, Hu Y. Key Genes And Pathways Controlled By E2F1 In Human Castration-Resistant Prostate Cancer Cells. Onco Targets Ther 2019;12:8961-76. [PMID: 31802906 DOI: 10.2147/OTT.S217347] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
40 Zhang X. Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer. Cancer Commun (Lond) 2019;39:76. [PMID: 31753020 DOI: 10.1186/s40880-019-0425-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
41 Shi Q, Xu R, Song G, Lu H, Xue D, He X, Xia Y. GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6/STAT3 mechanism. Cancer Gene Ther 2020;27:726-38. [PMID: 31636361 DOI: 10.1038/s41417-019-0146-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
42 Melo Muniz VRV, Nunes FD, Xavier FCDA, Cangussu MCT, Almeida Freitas R, Cury PR, Gurgel CA, Santos JN. Potential role of Hedgehog signaling pathway and myofibroblastic differentiation in central giant cell granuloma—A preliminary study. J Oral Pathol Med 2019;48:855-60. [DOI: 10.1111/jop.12949] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Rice MA, Malhotra SV, Stoyanova T. Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer. Front Oncol. 2019;9:801. [PMID: 31555580 DOI: 10.3389/fonc.2019.00801] [Cited by in Crossref: 68] [Cited by in F6Publishing: 95] [Article Influence: 22.7] [Reference Citation Analysis]
44 Wang D, Zheng X, Fu B, Nian Z, Qian Y, Sun R, Tian Z, Wei H. Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling. EBioMedicine 2019;46:119-32. [PMID: 31375423 DOI: 10.1016/j.ebiom.2019.07.058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
45 Liu Z, Yang K, Yan X, Wang T, Jiang T, Zhou Q, Qi J, Qian N, Zhou H, Chen B, Huang P, Guo L, Zhang X, Xu X, Jiang M, Deng L. The effects of tranylcypromine on osteoclastogenesis in vitro and in vivo. FASEB J 2019;33:9828-41. [PMID: 31291555 DOI: 10.1096/fj.201802242RR] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
46 Tassone E, Bradaschia-Correa V, Xiong X, Sastre-Perona A, Josephson AM, Khodadadi-Jamayran A, Melamed J, Bu L, Kahler DJ, Ossowski L, Leucht P, Schober M, Wilson EL. KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone. Oncogene 2019;38:5766-77. [PMID: 31239516 DOI: 10.1038/s41388-019-0841-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
47 Lv Q, Wang D, Yang Z, Yang J, Zhang R, Yang X, Wang M, Wang Y. Repurposing antitubercular agent isoniazid for treatment of prostate cancer. Biomater Sci 2018;7:296-306. [PMID: 30468220 DOI: 10.1039/c8bm01189c] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
48 Hu YT, Li BF, Zhang PJ, Wu D, Li YY, Li ZW, Shen L, Dong B, Gao J, Zhu X. Dbx2 exhibits a tumor-promoting function in hepatocellular carcinoma cell lines via regulating Shh-Gli1 signaling. World J Gastroenterol 2019; 25(8): 923-940 [PMID: 30833799 DOI: 10.3748/wjg.v25.i8.923] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
49 Yang Z, Li W, Chen H, Mo Q, Li J, Zhao S, Hou C, Qin J, Su G. Inhibitor structure-guided design and synthesis of near-infrared fluorescent probes for monoamine oxidase A (MAO-A) and its application in living cells and in vivo. Chem Commun 2019;55:2477-80. [DOI: 10.1039/c8cc10084e] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 6.7] [Reference Citation Analysis]
50 Xiao G, Yao J, Kong D, Ye C, Chen R, Li L, Zeng T, Wang L, Zhang W, Shi X, Zhou T, Li J, Wang Y, Xu CL, Jiang J, Sun Y. The Long Noncoding RNA TTTY15, Which Is Located on the Y Chromosome, Promotes Prostate Cancer Progression by Sponging let-7. Eur Urol 2019;76:315-26. [PMID: 30527798 DOI: 10.1016/j.eururo.2018.11.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
51 Chu GC, Chung LWK, Gururajan M, Hsieh CL, Josson S, Nandana S, Sung SY, Wang R, Wu JB, Zhau HE. Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics. Asian J Urol 2019;6:65-81. [PMID: 30775250 DOI: 10.1016/j.ajur.2018.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
52 Guo S, Deng CX. Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation. Int J Biol Sci 2018;14:2083-93. [PMID: 30585271 DOI: 10.7150/ijbs.25720] [Cited by in Crossref: 75] [Cited by in F6Publishing: 109] [Article Influence: 18.8] [Reference Citation Analysis]
53 Sekino Y, Oue N, Mukai S, Shigematsu Y, Goto K, Sakamoto N, Sentani K, Hayashi T, Teishima J, Matsubara A, Yasui W. Protocadherin B9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients. Prostate 2019;79:234-42. [PMID: 30324761 DOI: 10.1002/pros.23728] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
54 Wang G, Zhao D, Spring DJ, DePinho RA. Genetics and biology of prostate cancer. Genes Dev 2018;32:1105-40. [PMID: 30181359 DOI: 10.1101/gad.315739.118] [Cited by in Crossref: 110] [Cited by in F6Publishing: 198] [Article Influence: 27.5] [Reference Citation Analysis]
55 Manzella N, Santin Y, Maggiorani D, Martini H, Douin-Echinard V, Passos JF, Lezoualc'h F, Binda C, Parini A, Mialet-Perez J. Monoamine oxidase-A is a novel driver of stress-induced premature senescence through inhibition of parkin-mediated mitophagy. Aging Cell 2018;17:e12811. [PMID: 30003648 DOI: 10.1111/acel.12811] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
56 Zhu Z, Chung YM, Sergeeva O, Kepe V, Berk M, Li J, Ko HK, Li Z, Petro M, DiFilippo FP, Lee Z, Sharifi N. Loss of dihydrotestosterone-inactivation activity promotes prostate cancer castration resistance detectable by functional imaging. J Biol Chem 2018;293:17829-37. [PMID: 30262668 DOI: 10.1074/jbc.RA118.004846] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
57 Celià-Terrassa T, Kang Y. Metastatic niche functions and therapeutic opportunities. Nat Cell Biol 2018;20:868-77. [PMID: 30050120 DOI: 10.1038/s41556-018-0145-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 78] [Article Influence: 16.3] [Reference Citation Analysis]
58 Dhabal S, Das P, Biswas P, Kumari P, Yakubenko VP, Kundu S, Cathcart MK, Kundu M, Biswas K, Bhattacharjee A. Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13-stimulated monocytes and A549 lung carcinoma cells. J Biol Chem 2018;293:14040-64. [PMID: 30021838 DOI: 10.1074/jbc.RA118.002321] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
59 Lv Q, Yang X, Wang M, Yang J, Qin Z, Kan Q, Zhang H, Wang Y, Wang D, He Z. Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye–monoamine oxidase A inhibitor conjugate. Journal of Controlled Release 2018;279:234-42. [DOI: 10.1016/j.jconrel.2018.04.038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
60 Li Q, Alsaidan OA, Rai S, Wu M, Shen H, Beharry Z, Almada LL, Fernandez-Zapico ME, Wang L, Cai H. Stromal Gli signaling regulates the activity and differentiation of prostate stem and progenitor cells. J Biol Chem 2018;293:10547-60. [PMID: 29773652 DOI: 10.1074/jbc.RA118.003255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
61 Yin L, Li J, Liao CP, Jason Wu B. Monoamine Oxidase Deficiency Causes Prostate Atrophy and Reduces Prostate Progenitor Cell Activity. Stem Cells 2018;36:1249-58. [PMID: 29637670 DOI: 10.1002/stem.2831] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
62 Reis J, Manzella N, Cagide F, Mialet-perez J, Uriarte E, Parini A, Borges F, Binda C. Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis. J Med Chem 2018;61:4203-12. [DOI: 10.1021/acs.jmedchem.8b00357] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 7.5] [Reference Citation Analysis]
63 Liu G, Feng S, Jia L, Wang C, Fu Y, Luo Y. Lung fibroblasts promote metastatic colonization through upregulation of stearoyl-CoA desaturase 1 in tumor cells. Oncogene 2018;37:1519-33. [DOI: 10.1038/s41388-017-0062-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
64 Liu F, Hu L, Ma Y, Huang B, Xiu Z, Zhang P, Zhou K, Tang X. Increased expression of monoamine oxidase A is associated with epithelial to mesenchymal transition and clinicopathological features in non-small cell lung cancer. Oncol Lett. 2018;15:3245-3251. [PMID: 29435065 DOI: 10.3892/ol.2017.7683] [Cited by in Crossref: 11] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
65 Nyquist MD, Nelson PS. Anti-Depressant Therapy Brightens the Outlook for Prostate Cancer Bone Metastases. Cancer Cell 2017;31:303-5. [PMID: 28292431 DOI: 10.1016/j.ccell.2017.02.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
66 Halenova T, Savchuk O, Ostapchenko L, Chursov A, Fridlyand N, Komissarov AB, Venanzi F, Kolesnikov SI, Sufianov AA, Sherman MY, Gabai VL, Shneider AM. P62 plasmid can alleviate diet-induced obesity and metabolic dysfunctions. Oncotarget 2017;8:56030-40. [PMID: 28915571 DOI: 10.18632/oncotarget.19840] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
67 Stone L. Prostate cancer: Feel it in your bones: MAOA mediates metastasis. Nat Rev Urol 2017;14:326-7. [PMID: 28374794 DOI: 10.1038/nrurol.2017.52] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
68 Ferrarelli LK. Antidepressants protect bones from metastatic prostate cancer. Sci Signal 2017;10:eaan2866. [PMID: 28351947 DOI: 10.1126/scisignal.aan2866] [Cited by in F6Publishing: 1] [Reference Citation Analysis]